Medicine recalled amid quality concern
The Pharmacy and Poisons Board (PPB) and the National HIV and STI control program (NASCOP) has confirmed receipt of several product related market complaints for Tenofovir/Lamivudine/Dolutegravir (300/300/50mg) tablets manufactured by
Read on